Navigation Links
Gamma Pharmaceuticals, Inc. Holds Special Shareholders Meeting
Date:7/11/2011

tible debt financing.  Upon closing of this facility, it is intended that the first $200,000 will be used to bring current the Company's SEC filings, with the remainder of the line to be used to provide working capital.  Management stressed the fact that financing was now available to begin to bring the Company's products to market, and that Management and investors should be more interested in results on a monthly and quarterly basis than on longer range financial forecasts.  The Company undertook to host conference calls or webinars on a more frequent basis so that shareholders, potential investors and market participants will have greater visibility into the Company on a regular basis.  The Company also provided sample products to those attending the meeting.  Those wishing additional information on the Meeting may contact the Company's CFO, Joseph Cunningham at jcunningham@gammapharma.com or at (651) 204-2048.

About Gamma Pharmaceuticals Inc

Gamma Pharmaceuticals, Inc., (www.gammapharma.com) is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally.  Gamma's core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in the United States.  Branded nutritional supplements are sold under the trademarks Brilliant Choice™ nutritional supplements featuring the call to action "You've made a brilliant choice for your nutrition;"  SAVVY™  adult nutritional supplements featuring the call to action, "Be SAVVY Stay Healthy;" and,  Gamma Energy Products™ high performance supplements featuring the call to action, "Get your Gamma On."  Gamma's customer focus is on selling products in the Lifestyle of
'/>"/>

SOURCE Gamma Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Gamma Pharmaceuticals, Inc. Completes Sale and Books Revenue with National Pharmacy Chain
2. Elektas Leksell Gamma Knife Perfexion is Ranked 2011s Best in KLAS for Radiation Therapy
3. Devicor™ Medical Products, Inc. Agrees to Acquire Neoprobes Gamma Detection Devices
4. First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders
5. Elekta Emphasizes Advantages of Leksell Gamma Knife Perfexion Over Competing Systems at 2011 AANS Meeting
6. MEDX Installs Two Next Generation T-Quest™ Compact Gamma Cameras
7. New Technologies Open the Door for Low Dose Breast-Specific Gamma Imaging (BSGI) / Molecular Breast Imaging (MBI)
8. Health Diagnostic Laboratory, Inc. (HDL, Inc.) Partners With Gamma Therapeutics to Offer Breakthrough Diagnostic Assay for Heart Attack and Stroke Risk
9. MedClean Technologies Signs Contract with Gamma HealthCare Inc./Danner Medical Waste for MedClean 4500 Fixed-Based System, Services, and Consumables
10. Elekta to Highlight Latest Gamma Knife Surgery Innovations at Annual Neurosurgery Conference
11. Worlds Tallest Man Stretches Out—Over Eight Feet—for Needed Gamma Knife Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... , April 20, 2015 This report analyzes ... in US$ Million by the following Product Segments: Sphygmomanometers (Aneroid ... Blood Pressure Transducers. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... Latin America . Annual estimates and forecasts are ...
(Date:4/20/2015)... FRANCISCO , April 20, 2015  SillaJen, ... the development of oncolytic immunotherapy products for cancer, ... research at the Annual Meeting of the American ... of a murine adapted version of its lead ... Pexa-Vec is an oncolytic immunotherapy designed to ...
(Date:4/20/2015)... MENLO PARK, Calif. , April 20, 2015 ... device company, announced today the closing of an $18.5 ... and Aisling Capital.  Existing investors Aperture Venture Partners, ... in the round.  Spirox, which is developing a ... Ear, Nose and Throat (ENT) physicians and plastic ...
Breaking Medicine Technology:World Blood Pressure Monitoring and Measurement Instruments Industry 2World Blood Pressure Monitoring and Measurement Instruments Industry 3World Blood Pressure Monitoring and Measurement Instruments Industry 4World Blood Pressure Monitoring and Measurement Instruments Industry 5World Blood Pressure Monitoring and Measurement Instruments Industry 6World Blood Pressure Monitoring and Measurement Instruments Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 8World Blood Pressure Monitoring and Measurement Instruments Industry 9World Blood Pressure Monitoring and Measurement Instruments Industry 10World Blood Pressure Monitoring and Measurement Instruments Industry 11World Blood Pressure Monitoring and Measurement Instruments Industry 12World Blood Pressure Monitoring and Measurement Instruments Industry 13World Blood Pressure Monitoring and Measurement Instruments Industry 14World Blood Pressure Monitoring and Measurement Instruments Industry 15World Blood Pressure Monitoring and Measurement Instruments Industry 16World Blood Pressure Monitoring and Measurement Instruments Industry 17World Blood Pressure Monitoring and Measurement Instruments Industry 18World Blood Pressure Monitoring and Measurement Instruments Industry 19World Blood Pressure Monitoring and Measurement Instruments Industry 20World Blood Pressure Monitoring and Measurement Instruments Industry 21World Blood Pressure Monitoring and Measurement Instruments Industry 22World Blood Pressure Monitoring and Measurement Instruments Industry 23World Blood Pressure Monitoring and Measurement Instruments Industry 24World Blood Pressure Monitoring and Measurement Instruments Industry 25World Blood Pressure Monitoring and Measurement Instruments Industry 26World Blood Pressure Monitoring and Measurement Instruments Industry 27World Blood Pressure Monitoring and Measurement Instruments Industry 28SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 2SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 3Spirox, Inc. Announces Closing of $18.5MM Series B Financing 2Spirox, Inc. Announces Closing of $18.5MM Series B Financing 3
... Sept. 26, 2011 Luminex Corporation (NASDAQ: ... xMAP Europe 2011, its annual European multiplexing technology symposium, ... The event will feature scientific sessions, workshops, discussion groups, ... around the world who are performing groundbreaking work in ...
... Sept. 26, 2011 Safely storing prescription medications ... other prescription holders. Now, an innovative new device ... dangerous medications—in a small, convenient and more portable ... Developed by CAP-N-LOCK, LLC., The ...
Cached Medicine Technology:Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna 2Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna 3Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna 4New Combination Locking Cap Designed to Protect Children and Teens From Prescription Medications 2
(Date:4/20/2015)... April 20, 2015 Early registration is ... and secure your space at the start line. Returning ... Olympic-distance race is limited to 500 participants (actually there’s only ... secured his spot). , Now thru April 30, the entry ... team members; after May 1st, the fee goes up to ...
(Date:4/20/2015)... TROY Healthcare Solutions will be hosting ... software, which provides the ultimate level of security for ... the Anthem Suite Hotel in the Socrates Room, located ... , Beginning at 7 AM, TROY Healthcare Solutions will ... Healthcare Solutions will offer brief 15-20 minute presentations each ...
(Date:4/20/2015)... "It's so hard to put into words ... I really thought I would just be paying for ... I've discovered is this need that other baby loss ... other and walk through this journey together," says Ramsey ... more from these families than I could ever hope ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Tympani ... that it grew its cloud services business 175% ... cloud computing services in addition to its traditional ... together with representatives from Tympani’s cloud partners Faction ... in enterprise-class cloud computing at a Cloud Symposium ...
(Date:4/20/2015)... 2015 The 2015 Market Research ... a professional and in-depth study on the current ... with a focus on the Chinese situation. ... besylate market research are Pfizer, Novartis, Daiichi Sankyo, ... Par Pharma, Cadila Pharmaceuticals, Kangya Pharmaceuticals, Rui Ming ...
Breaking Medicine News(10 mins):Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 2Health News:Hilo Triathlon Kicks Up Its Heels A Second Time; Early Bird Registration Available Online Now. 3Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that Could Save a Health System $100,000 3Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 2Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 3Health News:Tympani Grows Cloud Services Business 175%, Presents Cloud Symposium on April 23 2Health News:Tympani Grows Cloud Services Business 175%, Presents Cloud Symposium on April 23 3Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 2Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 3
... April 1 Avantis Medical Systems, Inc., ... devices, today announced that Matthew Jenusaitis of ConcepTx Medical, ... are pleased to invite someone of Mr. Jenusaitis, experience ... We look forward to working with him and expect ...
... Self-administered Alternative to Injections for Treatment of Vitamin ... Pharmaceuticals, the proprietary products division of a wholly ... PRX ), today announced it has ... Nasal Spray from QOL Medical LLC. ...
... Inc. (NYSE Amex Equities: KUN) ("China Shenghuo" or,the "Company"), reported financial ... Year 2008 Highlights, -- Total revenue for ... million, -- Gross margin ... provided by operating activities was $1.95 million, , ...
... PolyScript(R) Labels Enable Fast and Cost-Effective CustomizationSOUTHFIELD, Mich., April ... manufactured specifically to provide equipment with safety warnings or ... to help engineering industries meet the exacting demands made ... (R) and PolyScript ...
... Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading ... that David Gelfand, Ph.D., chief scientific officer, will ... of Science, Technology and Innovation,s (MOSTI) biotechnology conference ... be held April 2, 2009, at the Putrajaya ...
... Quantum Group, Inc. (NYSE Amex: QGP ) ( ... Continental Stock Transfer and Trust Company to act as Transfer ... & CEO, commented, "Continental Stock Transfer has been in business ... reputation as a comprehensive and customer-centric company that can facilitate ...
Cached Medicine News:Health News:Medical Device Industry Expert Matthew Jenusaitis Joins Avantis Medical Board of Directors 2Health News:Medical Device Industry Expert Matthew Jenusaitis Joins Avantis Medical Board of Directors 3Health News:Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical 2Health News:Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical 3Health News:Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical 4Health News:China Shenghuo Reports Year 2008 Financial Results 2Health News:China Shenghuo Reports Year 2008 Financial Results 3Health News:China Shenghuo Reports Year 2008 Financial Results 4Health News:China Shenghuo Reports Year 2008 Financial Results 5Health News:China Shenghuo Reports Year 2008 Financial Results 6Health News:China Shenghuo Reports Year 2008 Financial Results 7Health News:China Shenghuo Reports Year 2008 Financial Results 8Health News:China Shenghuo Reports Year 2008 Financial Results 9Health News:Schreiner ProTech Introduces Intelligent Marking Solutions Achieving Process and Cost Optimizations 2Health News:WaferGen's Chief Scientific Officer to Deliver Executive Talk at Malaysian Ministry of Science, Technology and Innovation's PCR Conference 2Health News:WaferGen's Chief Scientific Officer to Deliver Executive Talk at Malaysian Ministry of Science, Technology and Innovation's PCR Conference 3Health News:The Quantum Group Announces Transition to Continental Stock Transfer 2Health News:The Quantum Group Announces Transition to Continental Stock Transfer 3
Bio-Rad's Liquichek™ D-dimer Control provides the laboratory with a liquid, trilevel, human plasma based control for the monitoring of D-dimer testing on most automated coagulation, chemistry a...
Lyphochek Coagulation Control is a human plasma control for monitoring the performance of routine coagulation tests. It has an extended reconstituted stability which helps reduce waste and save money...
Lyphochek Diabetes Control is a human whole blood based product used to monitor hemoglobin fractions associated with diabetes, including Hemoglobins A1, A1C, F and Total Glycated Hemoglobin....
... Liquichek Qualitative Urine Toxicology Control is a ... rapid urine drug screen panels, including Point ... test kits like Bio-Rad TOX/See, Biosite Triage ... qualitative results (+/) for popular kits and ...
Medicine Products: